Jon Faiz Kayyem - 21 Dec 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Director
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Jon Faiz Kayyem
Issuer symbol: BDSX
Transactions as of: 21 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Dec 2022, 15:31:04 UTC
Previous filing: 21 Nov 2022
Next filing: 04 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+31,619			31,619	21 Dec 2022	Direct	F1
holding	BDSX	Common Stock						173,913	21 Dec 2022	By The Jon Faiz Kayyem Revocable Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-31,619	-100%	$0.000000^*	0	21 Dec 2022	Common Stock	31,619		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	These securities are directly owned by The Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
F3	These restricted stock units vested in full on December 5, 2022 and were settled in shares of Common Stock on December 21, 2022. These restricted stock units had no expiration date.